Two such limitations are that SP and LOC389641 were not detected in clinical tissue samples, and the effects of the SP/NK-1R axis and LOC389641 on pancreatic cancer PNI lack validation in animal experiments. This evidence concerns the gene TACR1 and familial pancreatic carcinoma.